Product Information

METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.7188 per EA under NDC 00093534701. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jul 13, 2012.

METHYLPHENIDATE ER(LA) 30 MG CP

Methylphenidate Hydrochloride
$1.7188per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00093534701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079031

FDA Approved

7/13/2012

On Market Since

7/16/2012

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 60.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7188 per EA
All-time high$5.0876 (Sep 14, 2016)
All-time low$1.0799 (May 19, 2021)
52-week high$2.9073
52-week low$1.7188
Median price$3.1647
Average price$3.0999
Largest weekly change+71.5% (Aug 23, 2023)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-9.7%

3M

-15.8%

6M

-17.3%

1Y

-34.0%

3Y

-50.1%

5Y

+15.0%

All

-60.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $1.7188 per EA (NDC 00093534701), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 60.2%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?

Since Nov 28, 2013, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $1.0799 (May 19, 2021) to a high of $5.0876 (Sep 14, 2016), with a median of $3.1647 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 30 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?

METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00093534701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.